期刊
MOLECULAR BRAIN RESEARCH
卷 134, 期 1, 页码 24-33出版社
ELSEVIER
DOI: 10.1016/j.molbrainres.2004.09.028
关键词
Parkinson's disease; progression; positron emission tomography
Over the past two decades, positron emission tomography (PET) has provided valuable insights into the mechanisms of nigrostriatal degeneration in Parkinson's disease (PD). Furthermore, it allows the in vivo assessment of disease progression and the evaluation of treatment interventions. In this review, we shall discuss some of the issues and concerns that arise with the use of PET as a surrogate marker of disease progression in Parkinson's disease. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据